Skip to main content
. Author manuscript; available in PMC: 2022 Feb 1.
Published in final edited form as: Schizophr Res. 2021 Jan 23;228:298–304. doi: 10.1016/j.schres.2020.12.025

Table 1.

Characteristics among the full sample and by suicide ideation experience

Characteristic Full Sample (n=404) Experienced Suicide Ideationa (n=106) Didn’t Experience Suicide Ideationa (n=298) Sigb

n % or M ± SD n % or M ± SD n % or M ± SD
Age 404 23.62 ± 5.06 106 24.34 ± 4.85 298 23.36 ± 5.12
Gender
  Male 293 72.5 71 67.0 222 74.5
  Female 111 27.5 35 33.0 76 25.5
Race
  African American 152 37.6 46 43.4 106 35.6
  White 218 54.0 51 48.1 167 56.0
  American Indian or Alaska Native 21 5.2 5 4.7 16 5.4
  Asian 12 3.0 4 3.8 8 2.7
  Hawaiian or Pacific Islander 1 0.2 0 0.0 1 0.3
Ethnicity
  Hispanic/Latino 73 18.1 14 13.2 59 19.8
  Non-Hispanic/Latino 331 81.9 92 86.8 239 80.2
Marital Status
  Married 24 5.9 7 6.6 17 5.7
  Single/unmarried 358 88.6 95 89.6 263 88.3
  Divorced, widowed, or separated 22 5.4 4 3.8 18 6.0
Education
  Some high school or less 145 36.0 39 37.1 106 35.6
  Completed high school 133 33.0 39 37.1 94 31.5
  Some college or higher 125 31.0 27 25.7 98 32.9
Employment
  Currently working 58 14.4 13 12.3 45 15.1
  Not currently working 346 85.6 93 87.7 253 84.9
Insurance Type
  Private 82 20.4 18 17.3 64 21.5
  Public 127 31.7 34 32.7 93 31.3
  Uninsured 192 47.9 52 50.0 140 47.1
Residence
  Independent living 72 17.8 26 24.5 46 15.4
  Lives with family 287 71.0 67 63.2 220 73.8
  Supported or structured housing 14 3.5 3 2.8 11 3.7
  Homeless, shelter, or other 31 7.7 10 9.4 21 7.0
Medication Status *
  Using antipsychotics 337 83.4 81 76.4 256 85.9
  Not using antipsychotics 67 16.6 25 23.6 42 14.1
Months of untreated psychosis 355 6.36±8.62 105 8.57±9.56 298 5.58±8.14 **
Age of first psychiatric illness 398 16.52 ± 6.32 105 16.59 ± 6.20 293 16.49 ± 6.38
Age of first psychotic symptoms 392 19.15 ± 6.12 104 18.74 ± 6.11 288 19.30 ± 6.13
Number of psychiatric hospitalizations 314 1.94 ± 1.98
Symptoms of Depression 403 12.46 ± 4.04 105 15.41 ± 4.22 298 11.42 ± 3.42 ***
Positive Symptoms 403 18.77 ± 5.23 105 20.37 ± 4.86 298 18.20 ± 5.24 ***
Negative Symptoms 403 20.19 ± 5.31 105 20.86 ± 5.59 298 19.96 ± 5.20
Clinical insight 403 3.85 ± 1.08 105 3.60 ± .905 298 3.94 ± 1.12 **
Cognition
  Working memory 402 17.91 ± 4.61 106 17.30 ± 4.84 296 18.13 ± 4.52
  Attention and info processing speed 400 48.67 ± 13.47 105 48.88 ± 14.96 295 48.60 ± 12.94
  Executive functioning 400 15.61 ± 4.51 106 15.56 ± 4.59 294 15.63 ± 4.49
  Verbal memory 402 37.78 ± 11.48 106 38.13 ± 10.97 296 37.66 ± 11.68
  Verbal fluency 402 41.94 ± 11.95 106 41.94 ± 13.37 296 41.94 ± 11.42
  Motor speed 402 58.67 ± 15.36 106 58.51 ± 16.08 296 58.72 ± 15.12
DSM-IV Diagnosis ***
  Schizophrenia 214 53.0 50 47.2 164 55.0
  Schizoaffective bipolar 24 5.9 10 9.4 14 4.7
  Schizoaffective depressive 57 14.1 28 26.4 29 9.7
  Schizophreniform 67 16.6 10 9.4 57 19.1
  Brief psychotic disorder 2 0.5 0 0.0 2 0.7
  Psychotic disorder NOS 40 9.9 8 7.5 32 10.7
a

Measured from baseline to end of study; all other variables measured at baseline

b

Significance between suicide ideation groups examined using independent samples t-tests and chi-square tests

*

p<.05,

**

p<.01,

***

p<.001